IGF-1 LR3 Results Timeline
What the standard IGF-1 LR3 research protocol looks like phase by phase, over a typical 6–8 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Compare:IGF-1 LR3 vs HGH 191AA →
Quick Facts
FREQUENCYOnce daily
CYCLE LENGTH6–8 weeks
DOSE RANGE20–50 mcg/day
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2
Target dose: 20 mcg
Escalation
Weeks 3–4
Target dose: 30–40 mcg
Maintenance
Weeks 5–8
Target dose: 40–50 mcg
Reported in Research
- ✓6–8 weeks on, then 4–8 weeks off to prevent receptor desensitisation.
This timeline reflects the structure of the standard IGF-1 LR3 research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.